|
Volumn 19, Issue 3, 2002, Pages 251-253
|
Evolution of HIV disease in the third millennium: Clinical and related economic issues [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
BLOOD DERIVATIVE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ECONOMIC ASPECT;
FUTUROLOGY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HISTORY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
COHORT STUDIES;
HEALTH CARE COSTS;
HIV INFECTIONS;
HOSPITALIZATION;
HUMANS;
|
EID: 0036131019
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/S0924-8579(01)00494-0 Document Type: Letter |
Times cited : (11)
|
References (14)
|